Results 181 to 190 of about 6,725 (211)
Some of the next articles are maybe not open access.

Strabismus Surgery in Ocular Myasthenia gravis

Ophthalmologica, 2010
We evaluated the efficacy of eye muscle surgery in 4 patients with ocular myasthenia gravis with troublesome diplopia. All patients were in remission and had shown a consistently stable angle of deviation for at least 6 months preoperatively. The extent of eye muscle surgery was based on the degree of deviation in the primary position, and conventional
H, Ohtsuki   +3 more
openaire   +2 more sources

Therapeutic options in ocular myasthenia gravis

Neuromuscular Disorders, 2001
The term ocular myasthenia gravis refers to the disease clinically restricted to extrinsic ocular muscles. It can be disabling as ptosis, and to a greater extent diplopia, both interfere with daily activities. Although ocular disturbances are the most frequent initial complaints in myasthenic patients, symptoms usually progress to generalized disease ...
A, Evoli   +4 more
openaire   +2 more sources

Ocular myasthenia gravis.

Journal of the National Medical Association, 1994
Ocular dysfunction accounts for nearly 70% of the initial manifestations of myasthenia gravis. Since the prevalence rate of myasthenia gravis is two to 10 cases per 100,000 population, it is important for clinicians to be cognizant of this disorder and its varied ocular presentations.
G A, March, L N, Johnson
openaire   +1 more source

Immunotherapy of Ocular Myasthenia Gravis Reduces Conversion to Generalized Myasthenia Gravis

Journal of Neuro-Ophthalmology, 2003
Several retrospective studies have suggested that immunotherapy, including prednisolone, azathioprine and thymectomy, reduces progression of ocular myasthenia gravis to generalized myasthenia gravis. This study examines the effect of immunotherapy on generalization rates in ocular myasthenia patients who are acetylcholine receptor (AChR) antibody ...
Jared, Mee   +5 more
openaire   +2 more sources

Ocular Myasthenia Gravis

Odisha Journal of Ophthalmology, 2022
Guohong Tian, Xinghuai Sun, Ping Sun
  +5 more sources

Treatment of ocular symptoms in myasthenia gravis

Neurology, 2008
The choice between acetyl-cholinesterase inhibitors (AChE-Is) and steroids as symptomatic therapy for ocular symptoms in myasthenia is controversial.Thirty-five patients with myasthenia and ocular symptoms were evaluated by a single investigator. The ocular-quantitative myasthenia gravis (QMG) score was determined at each visit.
Minal J, Bhanushali   +2 more
openaire   +2 more sources

[Ocular myasthenia gravis].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2013
Ocular myasthenia gravis, although clinically often characterized by typical classical features, can cause considerable diagnostic problems. This article aims to provide a pragmatic approach to the pathogenesis, clinical features, diagnostics and therapeutic strategies in the clinical routine.
S, Pitz, B, Jordan, S, Zierz
openaire   +1 more source

Myasthenia Gravis: Systemic and Ocular Considerations

Ophthalmology, 1979
In the early 1930s, the neuromuscular junction was identified as the site of the abnormality in myasthenia gravis, based on the response of patients to anticholinesterase medication.3 It has since become apparent that acetylcholine, the natural transmitter, is synthesized chiefly in the motor nerve terminals4 and is stored in vesicles for subsequent ...
openaire   +2 more sources

Ocular Response to Corticotropin in Myasthenia Gravis

Archives of Ophthalmology, 1973
Twenty-two patients who had myasthenia gravis with ptosis, ophthalmoparesis, or both, were treated with massive doses of corticotropin (adrenocorticotrophic hormone). The ocular symptoms in eight of the patients improved significantly. Subsequently, four patients who failed to improve with corticotropin therapy had thymectomies, followed by ...
openaire   +2 more sources

Ocular Myasthenia Gravis

International Ophthalmology Clinics, 2007
Molly E, Gilbert, Peter J, Savino
openaire   +2 more sources

Home - About - Disclaimer - Privacy